RUA: Revenue growth and narrowed loss offset by ongoing liquidity and going concern risks

About this update from Rua Bioscience Ltd.

Revenue surged year-over-year, narrowing net loss and reflecting successful market expansion, but ongoing liquidity and going concern risks persist pending asset sale and further capital raising.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Rua Bioscience Ltd.